Clinical Trials in Ovarian Cancer
dc.contributor.author | Walsh, Christine | |
dc.date.accessioned | 2019-04-11 23:55 | |
dc.date.accessioned | 2020-02-25 03:00:28 | |
dc.date.accessioned | 2020-04-01T10:32:57Z | |
dc.date.available | 2020-04-01T10:32:57Z | |
dc.date.issued | 2017-01-16 | |
dc.identifier | 1004817 | |
dc.identifier | OCN: 966429822 | en_US |
dc.identifier.uri | http://library.oapen.org/handle/20.500.12657/25278 | |
dc.description.abstract | The first book to collect and synthesize cutting-edge research findings on the treatment of gynecological malignancies into one easy-to-use reference, Clinical Trials in Ovarian Cancer provides physicians with an invaluable resource. Gynecologic oncologist Christine S. Walsh systematically outlines each of the seminal Phase III trials that have shaped the treatment of ovarian cancers, detailing the rationale for the trial, the patient population studied, treatment delivery methods, efficacy, toxicity, and trial conclusions. | |
dc.language | English | |
dc.subject.classification | thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKC Gynaecology and obstetrics | en_US |
dc.subject.other | Medicine & Public Health | |
dc.subject.other | clinical trials | |
dc.subject.other | cancer | |
dc.subject.other | overian cancer | |
dc.subject.other | clinical medicine | |
dc.subject.other | health | |
dc.title | Clinical Trials in Ovarian Cancer | |
dc.type | book | |
oapen.identifier.doi | 10.2307/j.ctt1j7x9r2 | |
oapen.relation.isPublishedBy | 111d1c48-fc70-44ba-97fa-39be459ee343 | |
oapen.relation.isFundedBy | b818ba9d-2dd9-4fd7-a364-7f305aef7ee9 | |
oapen.relation.isbn | 9780813586496;9780813586489 | |
oapen.collection | Knowledge Unlatched (KU) | |
oapen.place.publication | New Brunswick | |
oapen.grant.number | 102219 | |
oapen.grant.program | KU Select 2018: STEM Backlist Books | |
oapen.identifier.isbn | 9780813586496 | |
grantor.number | 102219 | |
oapen.identifier.ocn | 966429822 |